Close Menu

NEW YORK (360Dx) – Ascenda Biosciences said today that it has acquired proteomic diagnostic firm Provista Diagnostics.

With the purchase, Alpharetta, Georgia-based Ascenda acquired New York City-headquartered Provista's Videssa Breast test, a blood-based proteomic test for assessing whether women with indeterminate mammogram readings should receive a biopsy or can be safely monitored without immediate follow-up.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
19
Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.